She was formerly the director of the Stanford Neuroendocrine Tumor Program before leaving, in part due to harassment.

Her father was a biologist specializing in the study of bats at Boston University.

[6] During her tenure at Stanford, Kunz's research focused on treating patients with gastrointestinal malignancies and neuroendocrine tumors, leading to the design, development and execution of clinical trials in this field.

[3] As an assistant professor of medicine, Kunz was appointed the medical director of the Stanford's Neuroendocrine Tumor Program, a program aimed at providing clinical care to patients with neuroendocrine tumors.

[8] Through this fellowship, she examined gender representation in her field including the disparities of women in clinical trials and leadership roles.